(Q34042430)

30 July 2017

title

Retargeting NK92 cells using an HLA-A2-restricted, EBNA3C-specific chimeric antigen receptor (English)

1 reference

30 July 2017

D V Tassev

1

1 reference

30 July 2017

M Cheng

series ordinal

2

1 reference

30 July 2017

N-K V Cheung

series ordinal

3

1 reference

30 July 2017

publication date

7 October 2011

1 reference

30 July 2017

1 reference

30 July 2017

volume

19

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

84-100

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2011.66

30 July 2017

exact match

0 references

cites work

Peptide-based cancer vaccines

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Adoptive T cell therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Application of adoptive T-cell therapy using tumor antigen-specific T-cell receptor gene transfer for the treatment of human leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Selected murine residues endow human TCR with enhanced tumor recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Minimal amino acid exchange in human TCR constant regions fosters improved function of TCR gene-modified T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

The promise and potential pitfalls of chimeric antigen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Chimeric antigen receptor-engineered T cells for immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Gene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Immunotherapy of malignant melanoma in a SCID mouse model using the highly cytotoxic natural killer cell line NK-92.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Near-infrared emitting fluorescent nanocrystals-labeled natural killer cells as a platform technology for the optical imaging of immunotherapeutic cells-based cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

EBNA3C interacts with Gadd34 and counteracts the unfolded protein response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Structure of the complex between human T-cell receptor, viral peptide and HLA-A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Coordinate regulation of complex T cell populations responding to bacterial infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Antibody arrays for high-throughput screening of antibody-antigen interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Peptide-induced stabilization and intracellular localization of empty HLA class I complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Molecular interactions mediating T cell antigen recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

The law of mass action governs antigen-stimulated cytolytic activity of CD8+ cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

CD107a as a functional marker for the identification of natural killer cell activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Antibody targeting to a class I MHC-peptide epitope promotes tumor cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

T cell retargeting with MHC class I-restricted antibodies: the CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

T cell activation by antibody-like immunoreceptors: increase in affinity of the single-chain fragment domain above threshold does not increase T cell activation against antigen-positive target cells but decreases selectivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

TCR-like human antibodies expressed on human CTLs mediate antibody affinity-dependent cytolytic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Redirected activity of human antitumor chimeric immune receptors is governed by antigen and receptor expression levels and affinity of interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Impact of peptides on the recognition of HLA class I molecules by human HLA antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Expression hierarchy of T cell epitopes from melanoma differentiation antigens: unexpected high level presentation of tyrosinase-HLA-A2 Complexes revealed by peptide-specific, MHC-restricted, TCR-like antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

The turnover kinetics of major histocompatibility complex peptides of human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Rapid enrichment of human papillomavirus (HPV)-specific polyclonal T cell populations for adoptive immunotherapy of cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8+ T-cell responses in patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

7 January 2021

Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

7 January 2021

Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

7 January 2021

Correlation between the number of T cell receptors required for T cell activation and TCR-ligand affinity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

7 January 2021

Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

7 January 2021

The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

7 January 2021

A T cell-independent antitumor response in mice with bone marrow cells retrovirally transduced with an antibody/Fc-gamma chain chimeric receptor gene recognizing a human ovarian cancer antigen

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

7 January 2021

Identification, isolation, and culture of HLA-A2-specific B lymphocytes using MHC class I tetramers

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.66

7 January 2021

Identifiers

DOI

10.1038/CGT.2011.66

1 reference

Dimensions Publication ID

30 July 2017

1042612902

0 references

1 reference